Parse

Parse indexes AI recommendations so brands know where they stand.

Products

  • Brands
  • Markets
  • Integrations
  • Work with us
  • Pricing
  • MCP

Resources

  • Research
  • Methodology
  • Blog

© 2026 Parse. All rights reserved.

LegalPrivacy PolicyTerms of Service
Parse
Work with usPricing
Sign inCheck your brand
  1. Brands
  2. iMednet
BrandsiMednet

How AI describes iMednet

Data as of Aug 25, 2026 · Based on 3,181,687 AI responses across 10,525 prompts · See how Parse measures this

iMednet logoiMednetmednetsolutions.com

MedNet Solutions provides iMednet, a configurable end-to-end clinical trial platform that integrates EDC and other modules to accelerate study startup and improve data quality. The platform uses AI to manage routine tasks, allowing clinical teams to focus on core research science.

Parse Score

36.0

#147 of 193 in Clinical Trial Management Software

Strength9
Reach30
Authority0

Work at iMednet?

Claim this profile for the full report: every prompt where iMednet appears, who is gaining, and what AI says about you. Claiming is free and unlocks your brand’s ambient view. Monitoring a market is the paid layer on top.

Verified with a work email.

Track this weekly.

Monitor iMednet

Sources

mednetsolutions.com shapes more of what AI says about iMednet than any other source, at 80% of its citations.

intuitionlabs.ai

AI questions where iMednet appears

Always know where you stand in AI

Start monitoring iMednet

The market map

Clinical Trial Management Software →
10%20%50%Category leadersSpecialistsIn the mixLong tailNamed in more AI answers →Appears earlier in the answer →MedidataVeevaIQVIAOracleRealTime eClinic…AdvarraCastor EDCSASOCT Clinical Tri…MedableHungaroTrialCrucial Data Sol…Trial InteractiveCloudbyz

Where AI ranks iMednet

Clinical Trial Management Software#147

  • Excerpts where iMednet appeared in the AI's answer

    Google AI Mode · excerpt
    iMednet (Mednet) : This platform offers a unified suite combining EDC, CTMS, and RTSM specifically designed for small to mid-sized trials